Ndatalyze Corp · CSE:NDAT
Ndatalyze — Investor Presentation (September 2022)
17 slides from Ndatalyze's investor presentation, Sep 13, 2022
Slide 1: nDatalyze Corp. Investor Presentation
nDatalyze Corp. CSE: NDAT OTCQB: NDATF Investor Presentation September 2022 www.nDatalyze.com
Slide 2: Forward-Looking Statements
nDatalyze Corp. Forward-Looking Statements Certain information set forth in this presentation contains “forward-looking information”, including “future-oriented financial information” and “financial outlook”, under applicable securities laws (collectively referred to herein as forward-looking statem
Slide 3: Mental Misdiagnosis Rates >50% – The Root Problem
Mental Misdiagnosis Rates >50% – The Root Problem General Major Panic Bipolar Anxiety Depressive Disorder Disorder Disorder Disorder 71% 65.9% 85.8% 92.7% Causes of Mis/Over Diagnosis • Lack of objective, evidence-based data • Interpretive bias of the clinician • Lack of deep correlation • Distracti
Slide 4: The YMI Solution – Corporate Snapshot
The YMI Solution – Corporate Snapshot nDatalyze’s flagship solution, YMI, is an expert system that uses machine learning to predict probabilities of personal mental health conditions. Addressed Conditions Depression PTSD Anxiety BiPolar Alcoholism Personality Disorder OCD ✓ Assess and manage mental
Slide 5: What's inside YMI?
What’s inside YMI? YMI is a Human-Machine mental health analyst “Memories” Digitized life experiences from >1200 people over multiple age groups with diversified backgrounds: a) Genetic expressions b) Childhood development c) Traumas & Allergies d) Doctor-diagnosed illnesses e) Physical conditions f
Slide 6: The Experts Behind the YMI System
The Experts Behind the YMI System James Durward Mr. Durward is a data scientist with decades of experience in technical product President, Founder, development. Over ten years of image analysis, pattern recognition and database development experience. Patented, published inventor with lengthy public
Slide 7: The Consumer Mobile Health (mHealth) Market
The Consumer Mobile Health (“mHealth”) Market Wearables / Heart Rate Monitors Telehealth DNA Test Kits (EKG) Brain Monitors Blood Pressure (EEG) Monitors CSE: NDAT | OTCQB: NDATF www.nDatalyze.com 7
Slide 8: mHealth Growth Projection
“mHealth” Growth Projection 11% CAGR Globally $130.6 billion globally $56.8 billion globally • The Problem: Infrastructure and procedures The diagnosis services segment “is expected to register • The Solution: mHealth (mobile health) the highest growth rate over the forecast period…” CSE: NDAT | OTC
Slide 9: How Mental Health is Diagnosed Today
How Mental Health is Diagnosed Today* Ham-D BDI DSM Clinician Amen Features (1) (2) Level 1 (3) Visits (4) Clinics (5) Anonymous Data ✔ ✔ ✔ # Questions Analyzed 250 17 21 23 Many Many # Conditions Addressed 7 1 1 Multiple Multiple Multiple Objective Data ✔ Some Some ✔ Biometric Correlation ✔ Some So
Slide 10: The YMI Process
The YMI Process YMI is an expert system that uses machine learning to predict probabilities of personal mental health conditions. Step 1 Step 2 Step 3 Reference Database Consumer and Ongoing self takes test machine-learning monitoring 35-40 min correlation/analysis CSE: NDAT | OTCQB: NDATF www.nData
Slide 11: The YMI Analysis – Reporting & Ongoing Monitoring
The YMI Analysis – Reporting & Ongoing Monitoring CSE: NDAT | OTCQB: NDATF www.nDatalyze.com 11
Slide 12: YMI Distribution Model
YMI Distribution Model Direct to the “mHealth” Consumer - Brand Ambassadors and Influencers - YMI Social media campaigns, Meta (Facebook), Instagram, TikTok - Highly-targeted digital ads Annual Subscription Annual Subscription Includes 1 report - Highly-compensated Referral System (Monthly pay) - Gr
Slide 13: The Management Team
The Management Team James Durward Mr. Durward is a data scientist with decades of experience in technical product development. Over ten years of image analysis, pattern recognition and database President, Founder, development experience. Patented, published inventor with lengthy public company Direc
Slide 14: YMI Development Timeline
YMI Development Timeline ✓ Mar 2021: Project Financing ✓ Mar 2021: Constructed questionnaire and EEG process, began database build ✓ May 2021: Started machine-learning and questionnaire development ✓ July 2021: Filed US patent application ✓ Nov 2021: Completed Reference Database >1200 participants,
Slide 15: YMI Development Timeline
YMI Development Timeline Funded through to Initial Revenues ❑ Q3-Q4 2022: YMI Market Testing – Targeted marketing with ads and influencers ❑ Q3-Q4 2022: Commercially Launch YMI – Refine and expand marketing geographically ❑ Q4 2022: Initial Revenues ❑ Q4 2022: Targeted Marketing to Clinicians CSE: N
Slide 16: Share Metrics & Highlights
Share Metrics & Highlights CSE: NDAT, OTCQB: NDATF Investor Highlights Market Cap C$8.5 M ✓ YMI launching in Q3-Q4 2022 Share Price C$0.22 ✓ Funded to launch with no debt 52-week Range C$0.12 - C$0.36 ✓ U.S. Patent Pending Shares Outstanding 38.71 M ✓ Proprietary Reference Database ✓ Advanced consum
Slide 17: Contact Us
CONTACT US nDatalyze Corp. 707 - 7th Avenue SW, Suite 1150 Calgary, Alberta T2P 3H6, Canada www.nDatalyze.com James Durward Investor Relations President RB Milestone Group LLC (RBMG) jimd@ndatalyze.com New York, NY | Stamford, CT ndatalyze@rbmilestone.com CSE: NDAT | OTCQB: NDATF www.nDatalyze.com 1